longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

FOXO Settles J.H. Darbie Claims With 400 Series D Preferred Shares and $175,000 Cash

TradingView
May 22, 2026 at 09:23 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

FOXO Technologies has settled claims with J.H. Darbie by issuing 400 Series D preferred shares and agreeing to pay $175,000 in installments from May to December 2026. If FOXO defaults, J.H. Darbie can convert unpaid amounts into Class A Common Stock at a specified rate. The agreement aims to resolve prior obligations under various agreements.

FOXO Technologies entered into a Settlement Agreement and Release with J.H. Darbie to resolve all obligations under prior finder, advisory, and private placement agreements. FOXO will issue 400 shares of Series D cumulative convertible redeemable preferred stock and pay $175,000 in seven monthly $25,000 installments from May through December 2026. If FOXO defaults on payments, J.H. Darbie may convert the unpaid balance into Class A Common Stock at 90% of the 20-day VWAP, capped at 4.99% beneficial ownership. J.H. Darbie also received piggyback registration rights for conversion shares.

Agreement details:

  • Agreement type: Settlement Agreement and Release resolving prior finder, advisory, and private placement obligations
  • Counterparty: J.H. Darbie & Co.
  • Signed / Effective: May 15 2026 / same
  • Duration / Termination: Through Dec 31 2026
  • Reason: Resolve outstanding obligations to J.H. Darbie

Original SEC Filing: FOXO TECHNOLOGIES INC. [ FOXO ] - 8-K - May. 22, 2026

Disclaimer
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

Login to unlock671characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Recommended Readings

  • Apr 20, 2026 at 06:34 PMEli Lilly Announces $7 Billion Acquisition of Kelonia: Pioneering the 'In Vivo CAR-T' Frontier and Leading Gene Therapy …
  • Apr 16, 2026 at 11:12 AMUS Stocks Hit New Highs, Retail Investors Miss Out en masse: Tom Lee Says Next Rally Will Be Led by Them
  • Apr 7, 2026 at 10:32 PMReminder: Key events to watch intraday (all times Beijing Time)
  • Apr 7, 2026 at 03:50 PMGoldman Sachs Issues Rare Call: "Generational Buying Opportunity" for US Tech Stocks Has Quietly Begun
  • Apr 1, 2026 at 11:11 PMEli Lilly's Oral Weight-Loss Drug Foundayo Approved, the Only One That Can Be Taken Anytime Without Fasting

Related Stocks

FOXO TECHNOLOGIES INC

FOXO TECHNOLOGIES INC

USFOXOW

0.00%

FOXO Tech

FOXO Tech

USFOXO

SPDR S&P Biotech

SPDR S&P Biotech

USXBI

LongbridgeAI